{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:14:02Z","timestamp":1754162042932,"version":"3.41.2"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Elderly constitute a high-risk subset of patients but are under-represented in clinical revascularization trials. Our aim was to investigate clinical outcomes and prognosis predictors after percutaneous coronary intervention (PCI) in this population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Unrestricted consecutive patients with \u226575 years who underwent PCI from 2012 to 2015 were enrolled. The primary ischemic endpoint was the composite of 1-year myocardial infarction, definite\/probable stent thrombosis and target vessel revascularization. The primary bleeding endpoint was defined according to the Bleeding Academic Research Consortium (BARC) classification as BARC \u2265 2.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We enrolled 708 patients (mean age 80 \u00b1 4): 14% were very elderly patients (\u226585 years), 27% of patients were diabetic, 23% had chronic kidney disease (CKD), 17% atrial fibrillation and 37% presented acute coronary syndrome. The primary ischemic endpoint was reported in 67 patients (12%): 29 had myocardial infarction (5%), 25 had definite\/probable stent thrombosis (4.4%) and 44 had target vessel revascularization (8%). BARC \u2265 2 bleeding was reported in 43 patients (8%). No differences were found in terms of both ischemic and bleeding events between patients with &lt;85 and \u226585 years. Three-vessel disease and use of bare metal stent were independent predictors of the primary ischemic endpoint. Triple antithrombotic therapy and CKD were the only independent predictors of BARC \u2265 2 bleedings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In our experience, elderly patients reported reassuring efficacy and safety outcomes after PCI, even if ischemic and bleeding events were frequent. Three-vessel disease and the use of bare metal stent were the only predictors of primary ischemic endpoint. Triple antithrombotic therapy and CKD were the only predictors of BARC \u2265 2 bleedings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001028","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T11:18:06Z","timestamp":1614338286000},"page":"689-697","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["One-year clinical outcome and predictors of ischemic and hemorrhagic events after percutaneous coronary intervention in elderly and very elderly patients"],"prefix":"10.1097","volume":"32","author":[{"given":"Alberto","family":"Monello","sequence":"first","affiliation":[{"name":"Cardio-Thoracic-Vascular Department, San Raffaele Institute, Milan"},{"name":"Interventional Cardiology, \u201cG. da Saliceto\u201d Hospital, Piacenza"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Chiarito","sequence":"additional","affiliation":[{"name":"Cardio-Thoracic-Vascular Department, San Raffaele Institute, Milan"},{"name":"Humanitas Clinical and Research Center, Clinical and Interventional Cardiology, Rozzano"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Andrea","family":"Pivato","sequence":"additional","affiliation":[{"name":"Cardio-Thoracic-Vascular Department, San Raffaele Institute, Milan"},{"name":"Humanitas Clinical and Research Center, Clinical and Interventional Cardiology, Rozzano"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Scotti","sequence":"additional","affiliation":[{"name":"Cardio-Thoracic-Vascular Department, San Raffaele Institute, Milan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Melillo","sequence":"additional","affiliation":[{"name":"Cardio-Thoracic-Vascular Department, San Raffaele Institute, Milan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Munaf\u00f2","sequence":"additional","affiliation":[{"name":"Cardio-Thoracic-Vascular Department, San Raffaele Institute, Milan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Montorfano","sequence":"additional","affiliation":[{"name":"Cardio-Thoracic-Vascular Department, San Raffaele Institute, Milan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Margonato","sequence":"additional","affiliation":[{"name":"Cardio-Thoracic-Vascular Department, San Raffaele Institute, Milan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Colombo","sequence":"additional","affiliation":[{"name":"Cardio-Thoracic-Vascular Department, San Raffaele Institute, Milan"},{"name":"Emo-GVM Centro Cuore Columbus, Milan"},{"name":"Interventional Cardiology Unit, Maria Cecilia Hospital, Cotignola, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosmo","family":"Godino","sequence":"additional","affiliation":[{"name":"Cardio-Thoracic-Vascular Department, San Raffaele Institute, Milan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jacc.2005.05.084","article-title":"Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE national quality improvement initiative.","volume":"46","author":"Alexander","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0735-1097(01)01432-2","article-title":"Acute myocardial infarction in the elderly: differences by age.","volume":"38","author":"Mehta","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","article-title":"ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina\/non-st-elevation myocardial infarction) developed in collaboration with the American College of emergency physicians, the society for cardiovascular angiography and interventions, and the society of thoracic surgeons endorsed by the American Association of Cardiovascular and pulmonary rehabilitation and the society for academic emergency medicine.","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.107.188209","article-title":"2007 focused update of the ACC\/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines: developed in collaboration with the Canadian cardiovascular society endorsed by the American Academy of family physicians: 2007 writing group to review new evidence and update the ACC\/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee.","volume":"117","author":"Antman","year":"2008","journal-title":"Circulation"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCINTERVENTIONS.108.826172","article-title":"Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: national cardiovascular data registry experience.","volume":"2","author":"Singh","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1161\/CIRCULATIONAHA.107.182615","article-title":"Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on clinical cardiology: in collaboration with the society of geriatric cardiology.","volume":"115","author":"Alexander","year":"2007","journal-title":"Circulation"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.286.6.708","article-title":"Representation of elderly persons and women in published randomized trials of acute coronary syndromes.","volume":"286","author":"Lee","year":"2001","journal-title":"JAMA"},{"issue":"Suppl C","key":"R8-20250729","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/eurheartj\/11.suppl_C.22","article-title":"Changes in cardiovascular function with aging.","volume":"11","author":"Lakatta","year":"1990","journal-title":"Eur Heart J"},{"key":"R9-20250729","first-page":"1792","article-title":"Economic evaluation of bivalirudin with provisional glycoprotein IIB\/IIIA inhibition versus heparin with routine glycoprotein IIB\/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial.","volume":"44","author":"Cohen","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1067\/mhj.2001.119371","article-title":"Predictors of length of stay after coronary stenting.","volume":"142","author":"Aronow","year":"2001","journal-title":"Am Heart J"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction.","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.82.4.1193","article-title":"Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel angioplasty prognosis study group.","volume":"82","author":"Ellis","year":"1990","journal-title":"Circulation"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/annrheumdis-2014-206186","article-title":"Statistical review: frequently given comments.","volume":"74","author":"Lydersen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/0895-4356(95)00510-2","article-title":"Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy.","volume":"48","author":"Concato","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression.","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(17)32713-7","article-title":"Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial.","volume":"391","author":"Varenne","year":"2018","journal-title":"Lancet"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jacc.2013.10.053","article-title":"A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision stents for the management of angina in the elderly).","volume":"63","author":"de Belder","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/eurheartj\/ehr407","article-title":"High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study.","volume":"33","author":"Silvain","year":"2012","journal-title":"Eur Heart J"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1606915","article-title":"Acute myocardial infarction.","volume":"376","author":"Anderson","year":"2017","journal-title":"N Engl J Med"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0002-9149(90)90500-Z","article-title":"Results of percutaneous transluminal coronary angioplasty in patients greater than or equal to 65 years of age (from the 1985 to 1986 national heart, lung, and blood institute\u2019s coronary angioplasty registry).","volume":"66","author":"Kelsey","year":"1990","journal-title":"Am J Cardiol"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jacc.2015.10.043","article-title":"Causes of death following PCI versus CABG in complex CAD: 5-year follow-Up of SYNTAX.","volume":"67","author":"Milojevic","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.amjcard.2015.01.557","article-title":"Comparison among patients\u226575 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents.","volume":"115","author":"Mangiacapra","year":"2015","journal-title":"Am J Cardiol"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.amjcard.2010.07.007","article-title":"Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH registries).","volume":"106","author":"Cheng","year":"2010","journal-title":"Am J Cardiol"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacc.2011.10.853","article-title":"Percutaneous coronary intervention and drug-eluting stent use among patients \u226585 years of age in the United States.","volume":"59","author":"Wang","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.amjcard.2008.08.021","article-title":"Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.","volume":"102","author":"Rossini","year":"2008","journal-title":"Am J Cardiol"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1540-8183.2009.00468.x","article-title":"Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting.","volume":"22","author":"Rubboli","year":"2009","journal-title":"J Interv Cardiol"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archinte.167.2.117","article-title":"Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials.","volume":"167","author":"Dentali","year":"2007","journal-title":"Arch Intern Med"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","article-title":"Concomitant use of antiplatelet therapy with dabigatran or warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.","volume":"127","author":"Dans","year":"2013","journal-title":"Circulation"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:04:59Z","timestamp":1753812299000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001028","relation":{},"ISSN":["0954-6928"],"issn-type":[{"type":"print","value":"0954-6928"}],"subject":[],"published":{"date-parts":[[2021,2,12]]}}}